Acadian Asset Management’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$668M Sell
11,593,352
-294,316
-2% -$16.9M 0.79% 27
2026
Q1
$721M Buy
11,887,668
+5,914,144
+99% +$345M 1.02% 19
2025
Q4
$322M Buy
5,973,524
+2,895,720
+94% +$139M 0.53% 44
2025
Q3
$139M Buy
3,077,804
+1,302,747
+73% +$60.8M 0.24% 90
2025
Q2
$82.2M Buy
1,775,057
+1,607,363
+959% +$78.9M 0.17% 121
2025
Q1
$10.2M Sell
167,694
-45,553
-21% -$2.66M 0.03% 328
2024
Q4
$12.1M Sell
213,247
-77,320
-27% -$4.32M 0.04% 318
2024
Q3
$15M Sell
290,567
-56,807
-16% -$2.66M 0.05% 275
2024
Q2
$14.4M Sell
347,374
-272,950
-44% -$12.2M 0.04% 280
2024
Q1
$33.6M Buy
620,324
+268,006
+76% +$13.7M 0.12% 157
2023
Q4
$18.1M Sell
352,318
-410,363
-54% -$21.5M 0.07% 220
2023
Q3
$44.3M Sell
762,681
-371,495
-33% -$22.8M 0.19% 138
2023
Q2
$72.5M Sell
1,134,176
-328,058
-22% -$22M 0.3% 97
2023
Q1
$101M Buy
1,462,234
+260,092
+22% +$18.3M 0.44% 64
2022
Q4
$86.5M Buy
1,202,142
+15,862
+1% +$1.2M 0.43% 74
2022
Q3
$84.3M Buy
1,186,280
+892,600
+304% +$64.7M 0.46% 63
2022
Q2
$22.6M Buy
293,680
+276,011
+1,562% +$21M 0.12% 176
2022
Q1
$1.29M Buy
17,669
+13,349
+309% +$896K 0.01% 774
2021
Q4
$269K Hold
4,320
﹤0.01% 1163
2021
Q3
$255K Hold
4,320
﹤0.01% 1229
2021
Q2
$289K Hold
4,320
﹤0.01% 1326
2021
Q1
$273K Hold
4,320
﹤0.01% 1398
2020
Q4
$268K Hold
4,320
﹤0.01% 1442
2020
Q3
$260K Hold
4,320
﹤0.01% 1362
2020
Q2
$254K Hold
4,320
﹤0.01% 1412
2020
Q1
$241K Hold
4,320
﹤0.01% 1156
2019
Q4
$277K Hold
4,320
﹤0.01% 1215
2019
Q3
$219K Sell
4,320
-13,184
-75% -$620K ﹤0.01% 1299
2019
Q2
$794K Sell
17,504
-31,449
-64% -$1.46M ﹤0.01% 865
2019
Q1
$2.33M Sell
48,953
-33,992
-41% -$1.69M 0.01% 651
2018
Q4
$4.31M Buy
82,945
+47,426
+134% +$2.55M 0.02% 401
2018
Q3
$2.2M Sell
35,519
-176,268
-83% -$10.5M 0.01% 543
2018
Q2
$11.7M Buy
211,787
+195,381
+1,191% +$10.6M 0.05% 276
2018
Q1
$1.04M Sell
16,406
-3,279
-17% -$211K ﹤0.01% 722
2017
Q4
$1.21M Sell
19,685
-12,068
-38% -$755K 0.01% 662
2017
Q3
$2.02M Sell
31,753
-54,682
-63% -$3.19M 0.01% 558
2017
Q2
$4.82M Sell
86,435
-182,721
-68% -$9.94M 0.02% 403
2017
Q1
$14.6M Sell
269,156
-227,941
-46% -$12.5M 0.07% 237
2016
Q4
$29.1M Sell
497,097
-376,630
-43% -$20.6M 0.14% 151
2016
Q3
$47.1M Buy
873,727
+81,814
+10% +$5.26M 0.23% 118
2016
Q2
$58.2M Buy
791,913
+735,608
+1,306% +$52M 0.3% 102
2016
Q1
$3.6M Buy
56,305
+13,360
+31% +$843K 0.02% 454
2015
Q4
$2.95M Sell
42,945
-13,799
-24% -$912K 0.02% 499
2015
Q3
$3.36M Sell
56,744
-11,064
-16% -$702K 0.02% 461
2015
Q2
$4.51M Buy
67,808
+40,436
+148% +$2.66M 0.02% 433
2015
Q1
$1.77M Buy
27,372
+26,840
+5,045% +$1.68M 0.01% 565
2014
Q4
$31K Sell
532
-7,356
-93% -$415K ﹤0.01% 1074
2014
Q3
$404K Sell
7,888
-5,567
-41% -$278K ﹤0.01% 691
2014
Q2
$652K Buy
13,455
+1,095
+9% +$54K ﹤0.01% 660
2014
Q1
$642K Hold
12,360
﹤0.01% 634
2013
Q4
$657K Sell
12,360
-52,067
-81% -$2.65M ﹤0.01% 642
2013
Q3
$2.98M Hold
64,427
0.02% 389
2013
Q2
$2.88M Buy
+64,427
New +$2.8M 0.02% 353

Other funds holding BMY

Acadian Asset Management's BMY Position: Q2 2026 in Review

Acadian Asset Management reduced its Bristol-Myers Squibb (BMY) stake by 2.5% in Q2 2026, selling an estimated $16.9M and leaving 11,593,352 shares worth $668M. The position accounts for 0.79% of the portfolio, ranked #27.

Acadian Asset Management first reported a position in BMY in Q2 2013 and has held it in 53 quarters since. The position peaked at $721M in Q1 2026. 2,142 funds tracked by Wall St. Rank hold BMY as of Q2 2026.

  • Acadian Asset Management held 11,593,352 shares of Bristol-Myers Squibb worth $668M as of Q2 2026.
  • Acadian Asset Management sold 294,316 Bristol-Myers Squibb shares in Q2 2026, an estimated $16.9M.
  • Bristol-Myers Squibb made up 0.79% of Acadian Asset Management's portfolio in Q2 2026, its #27 holding.
  • Acadian Asset Management first reported a position in Bristol-Myers Squibb in Q2 2013 and has held it in 53 quarters since.
  • Acadian Asset Management's Bristol-Myers Squibb position peaked at $721M in Q1 2026.
  • 2,142 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.

Based on Acadian Asset Management's 13F filing for Q2 2026, filed 13 Aug 2026.